Investors Sell Becton Dickinson and (BDX) on Strength Following Insider Selling

Traders sold shares of Becton Dickinson and Co (NYSE:BDX) on strength during trading on Thursday following insider selling activity. $77.93 million flowed into the stock on the tick-up and $124.23 million flowed out of the stock on the tick-down, for a money net flow of $46.30 million out of the stock. Of all stocks tracked, Becton Dickinson and had the 0th highest net out-flow for the day. Becton Dickinson and traded up $7.62 for the day and closed at $244.48Specifically, Director Timothy M. Ring sold 42,000 shares of Becton Dickinson and stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $237.07, for a total transaction of $9,956,940.00. Following the sale, the director now directly owns 93,688 shares of the company’s stock, valued at $22,210,614.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP James C. Lim sold 5,189 shares of Becton Dickinson and stock in a transaction that occurred on Thursday, November 8th. The shares were sold at an average price of $242.36, for a total value of $1,257,606.04. Following the sale, the executive vice president now directly owns 13,318 shares in the company, valued at $3,227,750.48. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by insiders.

BDX has been the topic of several recent analyst reports. Morgan Stanley boosted their target price on Becton Dickinson and from $250.00 to $280.00 and gave the stock an “equal weight” rating in a report on Thursday, October 4th. Wells Fargo & Co boosted their target price on Becton Dickinson and from $275.00 to $290.00 and gave the stock an “outperform” rating in a report on Thursday, September 6th. They noted that the move was a valuation call. Barclays initiated coverage on Becton Dickinson and in a report on Monday, October 15th. They issued an “equal weight” rating and a $278.00 target price on the stock. Royal Bank of Canada reissued a “hold” rating and issued a $248.00 target price on shares of Becton Dickinson and in a report on Friday, August 3rd. Finally, KeyCorp reissued a “buy” rating and issued a $264.00 target price on shares of Becton Dickinson and in a report on Friday, August 3rd. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $254.07.

The company has a quick ratio of 0.81, a current ratio of 1.23 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $64.40 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.44 and a beta of 1.19.

Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Tuesday, November 6th. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.93. Becton Dickinson and had a return on equity of 13.84% and a net margin of 1.47%. The firm had revenue of $4.40 billion for the quarter, compared to the consensus estimate of $4.36 billion. During the same quarter in the prior year, the business earned $2.40 EPS. The business’s revenue for the quarter was up 39.0% compared to the same quarter last year. As a group, equities research analysts predict that Becton Dickinson and Co will post 12.56 earnings per share for the current year.

A number of large investors have recently bought and sold shares of the business. Ascension Asset Management LLC lifted its holdings in Becton Dickinson and by 4.2% during the 2nd quarter. Ascension Asset Management LLC now owns 4,970 shares of the medical instruments supplier’s stock worth $1,191,000 after buying an additional 200 shares in the last quarter. Bfsg LLC lifted its holdings in Becton Dickinson and by 1.9% during the 2nd quarter. Bfsg LLC now owns 10,515 shares of the medical instruments supplier’s stock worth $2,519,000 after buying an additional 201 shares in the last quarter. Toth Financial Advisory Corp raised its position in shares of Becton Dickinson and by 0.8% during the 2nd quarter. Toth Financial Advisory Corp now owns 24,989 shares of the medical instruments supplier’s stock valued at $5,986,000 after acquiring an additional 203 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Becton Dickinson and by 0.4% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 50,849 shares of the medical instruments supplier’s stock valued at $12,181,000 after acquiring an additional 204 shares during the last quarter. Finally, Spearhead Capital Advisors LLC raised its position in shares of Becton Dickinson and by 1.4% during the 3rd quarter. Spearhead Capital Advisors LLC now owns 15,525 shares of the medical instruments supplier’s stock valued at $3,887,000 after acquiring an additional 218 shares during the last quarter. 92.60% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Investors Sell Becton Dickinson and (BDX) on Strength Following Insider Selling” was reported by WKRB News and is the sole property of of WKRB News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.wkrb13.com/2018/11/09/investors-sell-becton-dickinson-and-bdx-on-strength-following-insider-selling.html.

Becton Dickinson and Company Profile (NYSE:BDX)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems.

Featured Article: How are the companies in the S&P 500 selected?

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply